Outcomes of Biologic Use in Asian Compared with Non-Hispanic White Adult Psoriasis Patients from the CorEvitas Psoriasis Registry.

Yu, Chen; Wang, Gang; Burge, Russel T; Ye, Erjia; Dou, Guanshen; Li, Jinnan; Harrison, Ryan W; McLean, Robert R; Kerti, Samantha J; Bagel, Jerry

Yu, Chen; Wang, Gang; Burge, Russel T; Ye, Erjia; Dou, Guanshen; Li, Jinnan; Harrison, Ryan W; McLean, Robert R; Kerti, Samantha J; Bagel, Jerry.

Afiliación

Yu C; Department of Dermatology, Xijing Hospital, The Fourth Military Medical University, No. 127 Changle West Rd, Xi'an, 710032, People's Republic of China.
Wang G; Department of Dermatology, Xijing Hospital, The Fourth Military Medical University, No. 127 Changle West Rd, Xi'an, 710032, People's Republic of China. xjwgang@fmmu.edu.cn.
Burge RT; Eli Lilly and Company, Indianapolis, IN, USA.
Ye E; Eli Lilly and Company, Shanghai, People's Republic of China.
Dou G; Eli Lilly and Company, Shanghai, People's Republic of China.
Li J; Eli Lilly and Company, Shanghai, People's Republic of China.
Harrison RW; CorEvitas, LLC, Waltham, MA, USA.
McLean RR; CorEvitas, LLC, Waltham, MA, USA.
Kerti SJ; CorEvitas, LLC, Waltham, MA, USA.
Bagel J; Psoriasis Treatment Center of New Jersey, East Windsor, NJ, USA.

Dermatol Ther (Heidelb) ; 13(1): 187-206, 2023 Jan.

Article en En | MEDLINE | ID: mdl-36385699

Palabras clave

Biologic therapy; Effectiveness; Patient registries; Psoriasis; Race/ethnicity; Real-world evidence

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Aspecto: Patient_preference Idioma: En Revista: Dermatol Ther (Heidelb) Año: 2023 Tipo del documento: Article Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google